1. ALLA AKTIER
  2. NYHETER
  3. LIPUM

Lipum

Nyheter Lipum Nyheter alla bolag

Lipum AB – interim report for the period January-March 2023

MARKN.

Lipum AB (publ) has published the interim report for period January to March for 2023. Below is a summary, a complete report (only in Swedish) is available on the company's website.

CEO Einar Pontén comments: “I am excited about our ongoing Phase 1 clinical trial of the drug candidate SOL-116 as everything is going according to plan.”

Financial summary January - March 2023

  • Net sales: KSEK 0 (0)
  • Result after financial items: KSEK -7,173 (-5,830)
  • Cash and cash equivalents as of March 31: KSEK 26,765 (27,971)

Significant events during the period January - March 2023

  • The ongoing clinical phase 1 study with the drug candidate SOL-116 is progressing as planned after dosing four groups of healthy subjects.

Significant events after the period

  • Carl-Johan Spak was nominated as new board member of Lipum AB.

CEO Einar Pontén comments on the report in a live webcast on April 25 at 09:00, link.

Contacts
Einar Pontén, CEO
E-post: einar.ponten@lipum.se
Mobile: +46 70 578 34 95
Web: www.lipum.se

About Us
Lipum AB (publ) is a clinical stage biopharmaceutical company specialized in discovery and development of a novel treatment for chronic inflammatory diseases. The lead candidate SOL-116 is a humanized antibody designed to provide efficacious therapy by blocking a previously overlooked target molecule of the immune system (BSSL). SOL-116 is in clinical stage supported by solid data for rheumatoid arthritis. Lipum also explores other inflammatory diseases with a high unmet medical need. The company is based in Umeå, an excellent life science cluster in Sweden. Lipum’s unique approach has attracted international attention, including a major European Commission Horizon 2020 grant. The company's share (LIPUM) is traded on the Nasdaq First North Growth Market. Certified Adviser is G&W Fondkommission.

Attachments
Lipum AB – Kvartalsrapport Januari Mars 2023

Datum 2023-04-25, kl 08:00
Källa MFN
Bifogade filer
Lipum AB – Kvartalsrapport Januari Mars 2023
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!